Brief: Actuate Therapeutics Inc Files For Mixed Shelf Offering Of Up To $250 Million- SEC Filing
02/09/2025 22:47
Actuate Therapeutics Inc ACTU.O: ACTUATE THERAPEUTICS INC FILES FOR MIXED SHELF OFFERING OF UP TO $250 MILLION- SEC FILING Source text: [ID:n0001683168-25-006622] Further company coverage: ACTU.O
Recent news on Actuate Therapeutics
See all newsActuate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Actuate Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Health Rounds: Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
Brief: Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers
Brief: Actuate Therapeutics Inc - Reports Positive Phase 2 Trial Data For Elraglusib - SEC Filing